老年胃食管反流病的诊疗进展

周世平 ,  陈慧玲 ,  王丹

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 800 -803.

PDF (1159KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 800 -803. DOI: 10.3969/j.issn.1674-7593.2026.06.016
综述

老年胃食管反流病的诊疗进展

作者信息 +

Gastroesophageal reflux disease in the elderly: evolving diagnostic and therapeutic strategies

Author information +
文章历史 +
PDF (1186K)

摘要

胃食管反流病 (GERD) 是老年人常见的消化系统慢性疾病, 随着人口老龄化加剧, 其患病率呈逐年上升趋势。 老年 GERD 患者具有独特的临床特征, 症状不典型、 食管病变程度重、 并发症发生率高, 加之常合并多种基础疾病及多重用药, 导致诊断难度增加, 治疗策略复杂。 本文围绕老年 GERD 的诊断方法及治疗策略进展进行系统综述, 为其精准治疗提供新视角。

Abstract

Gastroesophageal reflux disease (GERD) is a prevalent chronic digestive system disorder in older adults, and its prevalence has been steadily rising in tandem with global population aging. Elderly patients with GERD present distinct clinical characteristics, including atypical symptoms, more severe esophageal mucosal injury, and a higher risk of complications. These features, compounded by the frequent presence of multiple comorbidities and polypharmacy, contribute to diagnostic difficulties and render therapeutic decision-making particularly complex. This article provides a comprehensive overview of current diagnostic approaches and evolving therapeutic strategies for GERD in the elderly, aiming to offer new perspectives for precision management in this vulnerable population.

关键词

老年人 / 胃食管反流病 / 诊断 / 治疗

Key words

Elderly / Gastroesophageal reflux disease / Diagnosis / Treatment

引用本文

引用格式 ▾
周世平,陈慧玲,王丹. 老年胃食管反流病的诊疗进展[J]. 国际老年医学杂志, 2026, 47(6): 800-803 DOI:10.3969/j.issn.1674-7593.2026.06.016

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Tack J, Pandolfino J E . Pathophysiology of gastroesophageal reflux disease [ J ]. Gastroenterology, 2018, 154(2): 277-288.

[2]

Dunbar K B, Agoston A T, Odze R D, et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes [ J ]. JAMA, 2016, 315 (19 ): 2104-2112.

[3]

Broderick R, Fuchs K H, Breithaupt W, et al. Clinical presentation of gastroesophageal reflux disease: a prospective study on symptom diversity and modification of questionnaire application[J]. Dig Dis, 2020, 38(3): 188-195.

[4]

Budzyński J, Pulkowski G, Suppan K, et al. Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey[J]. Health Qual Life Outcomes, 2011, 9(1): 77.

[5]

Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond study[J]. Gut, 2010, 59(6): 714-721.

[6]

Numans M E, Lau J, de Wit N J, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics [J]. Ann Intern Med, 2004, 140(7): 518-527.

[7]

Lundell L R, Dent J, Bennett J R, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification[J]. Gut, 1999, 45(2): 172-180.

[8]

Lin Y, Li Y, Liang M, et al. Acid exposure time > 6% might not improve the therapeutic outcome in Chinese gastroesophageal reflux disease patients[J]. J Neurogastroenterol Motil, 2021, 27(1): 55-62.

[9]

Kessing B F, Smout A J P M, Bredenoord A J . Clinical applications of esophageal impedance monitoring and high-resolution manometry[J]. Curr Gastroenterol Rep, 2012, 14(3): 197-205.

[10]

Xiao Y, Wu J C Y, Lu C L, et al. Clinical practice guidelines for esophageal ambulatory reflux monitoring in Chinese adults[J]. J Gastroenterol Hepatol, 2022, 37(5): 812-822.

[11]

Yadlapati R, Kahrilas P J, Fox M R, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0© [J]. Neurogastroenterol Motil, 2021, 33(1): e14058.

[12]

Dervin H, Bassett P, Sweis R . Esophagogastric junction contractile integral (EGJ-CI) complements reflux disease severity and provides insight into the pathophysiology of reflux disease [J]. Neurogastroenterol Motil, 2023, 35(8): e14597.

[13]

Meneghetti A T, Tedesco P, Damani T, et al. Esophageal mucosal damage may promote dysmotility and worsen esophageal acid exposure[J]. J Gastrointest Surg, 2005, 9(9): 1313-1317.

[14]

Jacobson B C, Somers S C, Fuchs C S, et al. Body-mass index and symptoms of gastroesophageal reflux in women [J]. N Engl J Med, 2006, 354(22): 2340-2348.

[15]

Vaezi M F, Yang Y X, Howden C W . Complications of proton pump inhibitor therapy [ J ]. Gastroenterology, 2017, 153(1): 35-48.

[16]

张晓莉, 李晗瑜, 郑松柏. 重视老年人胃食管反流病及其相关疾病的诊治[J]. 国际老年医学杂志, 2023, 44(4): 385-389.

[17]

Zhang X L, Li H Y, Zheng S B. Understanding and managing GERD and its associated conditions in the elderly: a comprehensive approach to diagnosis and treatment[J]. Int J Geriatr, 2023, 44(4): 385-389.

[18]

Savarino E V, Barberio B, Scarpignato C, et al. Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG)[J]. Dig Liver Dis, 2025, 57(8): 1550-1577.

[19]

Marakhouski K Y, Karaseva G A, Ulasivich D N, et al. Omeprazole-domperidone fixed dose combination vs omeprazole monotherapy: a phase 4, open-label, comparative, parallel randomized controlled study in mild to moderate gastroesophageal reflux disease [J]. Clin Med Insights Gastroenterol, 2017, 10: 117955221770945.

[20]

Meshkat S, Lin Q, Tassone V K, et al. Acid reflux medication use among adults with depressive symptoms[J]. J Affect Disord, 2025, 379: 747-754.

[21]

Liu W Z. Understanding the 2013 guidelines of diagnosis and management of gastroesophageal reflux disease issued by the American college of gastroenterology[J]. Chin J Gastroenterol, 2013, 18(4): 193-199.

[22]

王小兵, 胡素芹, 罗磊, 等. 老年难治性胃食管反流病的病因及治疗进展[J]. 国际老年医学杂志, 2026, 47(3): 352-356.

[23]

Wang X B, Hu S Q, Luo L, et al. Etiology andtherapeutic advances of refractory gastroesophageal reflux disease in the elderly[J]. Int J Geriatr, 2026, 47(3): 352-356.

[24]

Chang Y, Chen X, Tian Y, et al. Clinical effect of endoscopic cardial ligation and constriction for gastroesophageal reflux disease[J]. China J Endosc, 2020, 26(9): 19-24.

[25]

徐汤舟, 邱冰峰, 徐骐, 等. 套扎联合经口内镜下贲门缩窄术对难治性胃食管反流病患者症状改善的影响研究 [J]. 中国医师进修杂志, 2025, 48(2): 116-120.

[26]

Xu T Z, Qiu B F, Xu Q, et al. Effect of ligation combined with peroral endoscopic cardial constriction on symptom improvement in patients with refractory gastroesophageal reflux disease [ J ]. Chin J Postgrad Med, 2025, 48(2): 116-120.

[27]

Li X, Ye B M, Yao J X, et al. Study on the efficacy of endoscopic multi-point ligation of esophageal mucosal dentate line combined with vonopram fumarate in the treatment of refractory gastroesophageal reflux disease [J]. Chin Typ Case Database, 2025, 19(2): 231-235.

[28]

Weitzendorfer M, Köhler G, Antoniou S A, et al. Preoperative diagnosis of hiatal hernia: barium swallow X-ray, high-resolution manometry, or endoscopy [J]. Eur Surg, 2017, 49(5): 210-217.

基金资助

*吉林省教育厅科学研究项目(JJKH20250185KJ)

吉林省自然科学基金面上项目医学科学领域(YDZJ202401182ZYTS)

AI Summary AI Mindmap
PDF (1159KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉